カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の希少バイオマーカー検体採取＆安定化市場（2023-2030）：バイオマーカー別、エンドユーザー別（研究、診断）、地域別

【英語タイトル】Rare Biomarkers Specimen Collection And Stabilization Market Size, Share & Trends Analysis Report By Biomarker, By End-use (Research, Diagnostics), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV163）・商品コード：GRV23NOV163
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：209
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：バイオテクノロジー
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

希少バイオマーカー検体採取＆安定化市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の希少バイオマーカー検体採取＆安定化市場規模は2030年までに841億8000万米ドルに達し、予測期間中のCAGRは12.2%で拡大する見込みです。循環型希少バイオマーカーの潜在的用途の拡大は、これらの希少バイオマーカー検体の効果的かつ迅速な収集と安定化をサポートする製品の導入に携わる技術開発者にとって有利な機会を生み出しています。さらに、癌のスクリーニング、診断、予後予測、治療モニタリングのためのリキッドバイオプシーの出現は、希少バイオマーカー検体採取＆安定化の市場における競争と能力を著しく強化し、収益拡大に貢献しています。

循環型バイオマーカーは、高価値の治療デリバリーシステムとして、また潜在的な診断薬としての可能性があることから、研究者はより高感度で迅速かつ柔軟な分析ツールを採用しつつあります。主要企業は、研究の可能性を拡大するために、これらの希少バイオマーカー検体採取＆安定化のための新しい技術や製品を開発しています。相当数の利点があるにもかかわらず、臨床応用を克服するにはまだ課題があります。

ほとんどの分離方法は特異性が高く、感度が高いものの、これまでのところ、臨床サンプルにおける製品の使用と有効性に関する十分なエビデンスが不足しています。これは、これらの方法間の分析感度の違いが非常に重要な役割を果たすため、希少バイオマーカー検体の臨床利用の妨げとなっています。しかし、これらの希少バイオマーカー検体の臨床的有用性に関する研究の増加は、臨床実施に関連する課題を効果的に解決することが期待されます。

希少バイオマーカー検体採取＆安定化市場レポートハイライト

- 現在、cfDNAとCTCの合計が2022年の主要収益シェアを占めています。

- 臨床用として商業的に承認された製品の存在は、これらのセグメントにとってインパクトの大きいレンダリングドライバーの1つです。

- 循環RNAベースのバイオマーカーは、臨床用の市販製品がないため、市場浸透度は最も低いと推定されます。

- さらに、循環RNAの単離にはサンプルの純度や品質に関する課題があります。このことが、このセグメントの収益成長をかなり妨げています。

- エクソソーム／細胞外小胞および循環細胞遊離RNA（ccfRNA）／miRNAセグメントにおける分離キットおよび試薬の売上高シェアは、市販製品の購入頻度が高く、入手可能な範囲が広いことが大きな要因となっています。

- この分野での採血管の普及率が低いことに加え、使用率や購入率が比較的低いことが、この分野の収益の伸びを鈍らせています。

- 承認されたリキッドバイオプシー検査の存在とがん関連研究プログラムの急激な増加が、がん分野の優位性に寄与しています。

- 米国には主要なバイオテクノロジーおよび診断研究所が存在するため、北米が市場をリードしています。

- さらに、新規アッセイの承認に関する規制が明確であることも、同地域のシェア拡大に寄与しています。

- 希少バイオマーカーの検体採取・安定化市場で事業を展開している企業には、QIAGEN、Bio-Techne Corporation、Biocept, Inc、GILUPI GmbH、Norgen Biotek Corpなどがあります。

- 主要企業は製品ポートフォリオを強化するために様々な戦略を実施しており、様々な最終使用環境において多様な技術的に高度な分離製品を提供しています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 世界の希少バイオマーカー検体採取＆安定化市場：バイオマーカー別予測・動向分析
第5章. 世界の希少バイオマーカー検体採取＆安定化市場：最終用途別予測・動向分析
第6章. 世界の希少バイオマーカー検体採取＆安定化市場：地域別予測・動向分析
第7章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Biomarker
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Biomarker outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Rare Biomarkers Specimen Collection And Stabilization Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Rare Biomarkers Specimen Collection And Stabilization Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Rare Biomarkers Specimen Collection And Stabilization: Biomarker Estimates & Trend Analysis
4.1. Rare Biomarkers Specimen Collection And Stabilization Market: Key Takeaways
4.2. Rare Biomarkers Specimen Collection And Stabilization Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Circulating Cell Free DNA (ccfDNA)
4.3.1. Circulating cell free DNA (ccfDNA) market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4. Circulating Tumor Cells (CTCs)
4.4.1. Circulating tumor cells (CTCs) market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5. Exosomes/Extracellular Vesicles
4.5.1. Exosomes/Extracellular vesicles market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.2. Product
4.5.2.1. Product market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.2.2. Isolation kits & reagents
4.5.2.2.1. Isolation kits & reagents market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.2.3. Blood collection tubes
4.5.2.3.1. Blood collection tubes market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.2.4. Systems
4.5.2.4.1. Systems market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.3. Specimen type
4.5.3.1. Specimen type market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.3.2. Serum/Plasma
4.5.3.2.1. Serum/Plasma market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.3.3. Others
4.5.3.3.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.4. Nucleic acid & other biomolecules
4.5.4.1. Nucleic acid & other biomolecules market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.4.2. RNA
4.5.4.2.1. RNA market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.4.3. DNA
4.5.4.3.1. DNA market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.4.4. Others
4.5.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.5. Application
4.5.5.1. Application market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.5.2. NIPT
4.5.5.2.1. NIPT market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.5.3. Oncology
4.5.5.3.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.5.3.2. Research
4.5.5.3.2.1. Research market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.5.3.3. Diagnostics
4.5.5.3.3.1. Diagnostics market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.5.3.3.2. Screening
4.5.5.3.3.2.1. Screening market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.5.3.3.3. Treatment monitoring
4.5.5.3.3.3.1. Treatment Monitoring market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.5.4. Transcriptomics
4.5.5.4.1. Transcriptomics market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.5.5. Pharmacogenomics
4.5.5.5.1. Pharmacogenomics market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.5.6. Transplant rejection
4.5.5.6.1. Transplant rejection market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.5.7. Population screening
4.5.5.7.1. Population screening market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.5.8. Cardiovascular diseases
4.5.5.8.1. Cardiovascular diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.5.9. Other applications
4.5.5.9.1. Other applications market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6. Circulating Cell Free RNA (ccfRNA) / miRNA
4.6.1. Circulating cell free RNA (ccfRNA) / miRNAmarket estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.2. Product
4.6.2.1. Product market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.2.2. Isolation kits & reagents
4.6.2.2.1. Isolation kits & reagents market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.2.3. Blood collection tubes
4.6.2.3.1. Blood collection tubes market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.3. Application
4.6.3.1. Application market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.3.2. NIPT
4.6.3.2.1. NIPT market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.3.3. Oncology
4.6.3.3.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.3.3.2. Research
4.6.3.3.2.1. Research market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.3.3.3. Diagnostics
4.6.3.3.3.1. Diagnostics market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.3.4. Transcriptomics
4.6.3.4.1. Transcriptomics market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.3.5. Pharmacogenomics
4.6.3.5.1. Pharmacogenomics market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.3.6. Transplant rejection
4.6.3.6.1. Transplant rejection market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.3.7. Population screening
4.6.3.7.1. Population screening market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.3.8. Cardiovascular diseases
4.6.3.8.1. Cardiovascular diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.3.9. Other applications
4.6.3.9.1. Other applications market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 5. Rare Biomarkers Specimen Collection And Stabilization: End Use Estimates & Trend Analysis
5.1. Rare Biomarkers Specimen Collection and Stabilization Market: Key Takeaways
5.2. Rare Biomarkers Specimen Collection and Stabilization Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Research
5.3.1. Research market estimates and forecasts, 2018 to 2030 (USD Billion)
5.3.2. Research labs/CROs
5.3.2.1. Research labs/CROs market estimates and forecasts, 2018 to 2030 (USD Billion)
5.3.3. Academic institutes
5.3.3.1. Academic institutes market estimates and forecasts, 2018 to 2030 (USD Billion)
5.4. Diagnostics
5.4.1. Diagnostics market estimates and forecasts, 2018 to 2030 (USD Billion)
5.4.2. Laboratories
5.4.2.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Billion)
5.4.3. Hospitals
5.4.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Billion)
5.4.4. Prenatal clinics
5.4.4.1. Prenatal clinics market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 6. Rare Biomarkers Specimen Collection And Stabilization Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Rare Biomarkers Specimen Collection And Stabilization Market by Region: Key Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4.6. Denmark
6.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4.7. Sweden
6.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.4.8. Norway
6.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.7.2. Saudi Arabia
6.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Billion)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. QIAGEN
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Charles River Laboratories
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. F. Hoffmann-La Roche Ltd
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Thermofischer Scientific Inc.
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Eurofins Scientific
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. PerkinElmer Inc.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Bio-Rad Laboratories, Inc.
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Agilent Technologies, Inc
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Merck KGaA
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Siemens Healthcare GmbH
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 3 North America rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 4 North America rare biomarkers specimen collection and stabilization market, by region, 2018 - 2030 (USD Billion)
Table 5 U.S. rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 6 U.S. rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 7 Canada rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 8 Canada rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 9 Europe rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 10 Europe rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 11 Europe rare biomarkers specimen collection and stabilization market, by region, 2018 - 2030 (USD Billion)
Table 12 UK rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 13 UK rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 14 Germany rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 15 Germany rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 16 France rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 17 France rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 18 Italy rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 19 Italy rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 20 Spain rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 21 Spain rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 22 Denmark rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 23 Denmark rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 24 Sweden rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 25 Sweden rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 26 Norway rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 27 Norway rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 28 Asia Pacific rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 29 Asia Pacific rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 30 Asia Pacific rare biomarkers specimen collection and stabilization market, by region, 2018 - 2030 (USD Billion)
Table 31 Japan rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 32 Japan rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 33 China rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 34 China rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 35 India rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 36 India rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 37 Thailand rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 38 Thailand rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 39 South Korea rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 40 South Korea rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 41 Latin America rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 42 Latin America rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 43 Latin America rare biomarkers specimen collection and stabilization market, by region, 2018 - 2030 (USD Billion)
Table 44 Brazil rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 45 Brazil rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 46 Mexico rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 47 Mexico rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 48 Argentina rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 49 Argentina rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 50 Middle East and Africa rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 51 Middle East and Africa rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 52 Middle East and Africa rare biomarkers specimen collection and stabilization market, by region, 2018 - 2030 (USD Billion)
Table 53 South Africa rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 54 South Africa rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 55 Saudi Arabia rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 56 Saudi Arabia rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 57 UAE rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 58 UAE rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)
Table 59 Kuwait rare biomarkers specimen collection and stabilization market, by biomarker, 2018 - 2030 (USD Billion)
Table 60 Kuwait rare biomarkers specimen collection and stabilization market, by end use, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Rare biomarkers specimen collection and stabilization: Market outlook
Fig. 8 Rare biomarkers specimen collection and stabilization: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Rare biomarkers specimen collection and stabilization market driver impact
Fig. 14 Rare biomarkers specimen collection and stabilization market restraint impact
Fig. 15 Rare biomarkers specimen collection and stabilization market strategic initiatives analysis
Fig. 16 Rare biomarkers specimen collection and stabilization market: Biomarker movement analysis
Fig. 17 Rare biomarkers specimen collection and stabilization market: Biomarker outlook and key takeaways
Fig. 18 Circulating cell free DNA (ccfDNA) market estimates and forecasts, 2018 - 2030
Fig. 19 Circulating tumor cells (CTCs) market estimates and forecasts, 2018 - 2030
Fig. 20 Exosomes/extracellular vesicles market estimates and forecasts, 2018 - 2030
Fig. 21 Circulating cell free RNA (ccfRNA) / miRNA market estimates and forecasts, 2018 - 2030
Fig. 22 Rare biomarkers specimen collection and stabilization market: End use movement analysis
Fig. 23 Rare biomarkers specimen collection and stabilization market: End use outlook and key takeaways
Fig. 24 Research market estimates and forecasts, 2018 - 2030
Fig. 25 Diagnostics market estimates and forecasts, 2018 - 2030
Fig. 26 Global rare biomarkers specimen collection and stabilization market: Regional movement analysis
Fig. 27 Global rare biomarkers specimen collection and stabilization market: Regional outlook and key takeaways
Fig. 28 North America market estimates and forecasts, 2018 - 2030
Fig. 29 U.S. market estimates and forecasts, 2018 - 2030
Fig. 30 Canada market estimates and forecasts, 2018 - 2030
Fig. 31 Europe market estimates and forecasts, 2018 - 2030
Fig. 32 UK market estimates and forecasts, 2018 - 2030
Fig. 33 Germany market estimates and forecasts, 2018 - 2030
Fig. 34 France market estimates and forecasts, 2018 - 2030
Fig. 35 Italy market estimates and forecasts, 2018 - 2030
Fig. 36 Spain market estimates and forecasts, 2018 – 2030
Fig. 37 Denmark market estimates and forecasts, 2018 - 2030
Fig. 38 Sweden market estimates and forecasts, 2018 - 2030
Fig. 39 Norway market estimates and forecasts, 2018 - 2030
Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 41 Japan market estimates and forecasts, 2018 - 2030
Fig. 42 China market estimates and forecasts, 2018 - 2030
Fig. 43 India market estimates and forecasts, 2018 - 2030
Fig. 44 Australia market estimates and forecasts, 2018 - 2030
Fig. 45 Thailand market estimates and forecasts, 2018 - 2030
Fig. 46 South Korea market estimates and forecasts, 2018 - 2030
Fig. 47 Latin America market estimates and forecasts, 2018 - 2030
Fig. 48 Brazil market estimates and forecasts, 2018 - 2030
Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
Fig. 50 Argentina market estimates and forecasts, 2018 - 2030
Fig. 51 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 52 South Africa market estimates and forecasts, 2018 - 2030
Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 54 UAE market estimates and forecasts, 2018 - 2030
Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030

★調査レポート[世界の希少バイオマーカー検体採取＆安定化市場（2023-2030）：バイオマーカー別、エンドユーザー別（研究、診断）、地域別] (コード：GRV23NOV163)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の希少バイオマーカー検体採取＆安定化市場（2023-2030）：バイオマーカー別、エンドユーザー別（研究、診断）、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のリキッドバイオプシー(液体生検)市場2024-2030：バイオマーカー別（エクソソーム、CTC）、用途別（がん、生殖医療）、技術別、サンプルタイプ別、臨床用途別、エンドユーザー別、製品別、地域別
  • 世界の神経バイオマーカー市場（2023-2030）：用途別（アルツハイマー病、パーキンソン病、多発性硬化症、自閉症）、種類別、エンドユーザー別、地域別
  • 世界のノートパソコン市場（2023-2030）：種類別（従来型、2-in-1）、画面サイズ別、価格別、エンドユーザー別（パーソナル、ビジネス、ゲーム）、地域別
  • 世界のペーパー診断市場（2023-2030）：キット種類別（ラテラルフローアッセイ、ペーパーベースマイクロフルイディクス）、デバイス種類別（診断、モニタリング）、用途別、エンドユーザー別、地域別
  • 世界のスマートビルディング市場（2023-2030）：ソリューション別（安全・セキュリティ管理、エネルギー管理）、サービス別（コンサルティング、インプリメンテーション）、エンドユーザー別、地域別
  • 世界の超音波ジェル市場（2023-2030）：種類別（非滅菌、滅菌）、エンドユーザー別（病院、外来センター、クリニック）、地域別
  • 世界のプロテイナーゼK市場（2023-2030）：形態別（粉末、液体）、治療領域別（感染症、神経、腫瘍、循環器）、用途別、エンドユーザー別、地域別
  • 世界の手動車椅子市場（2023-2030）：カテゴリー別（成人、小児）、エンドユーザー別（病院、外来施設、在宅ケア）、地域別
  • 世界の医療用カート市場（2023-2030）：製品別（移動型コンピューティングカート、壁掛け型ワークステーション、薬剤）、種類別（麻酔、救急、処置）、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆